As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.
The company’s proprietary Digital Immune Optimized Synthetic Vaccine (DIOSynVax) platform uses artificial intelligence to create safer and stronger vaccines for today and smarter for tomorrow.
Beijing Synthetic Vaccine Biosciences Co. Ltd. has synthesized Toll-like receptor 8 (TLR8) agonists reported to be useful for the treatment of autoimmune disease, cancer, inflammatory disorders and ...
HHS Secretary Robert F. Kennedy Jr. issued a “call to action” and sent vaccines after the death of a child with measles in ...
Peptide-based vaccines deliver tumor-specific antigens to dendritic cells (DCs), triggering tumor-targeted T-cell responses. A peptide-peptide conjugate technology previously developed by researchers ...
In principle, mRNA vaccines are ideal for health emergencies ... aims to overcome these challenges by generating automated synthetic DNA templates, which don’t need to be grown in living cells ...